Related Experiment Video
Updated: Jul 8, 2025

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
Published on: June 27, 2015
T-2 Toxin-Mediated β-Arrestin-1 O-GlcNAcylation Exacerbates Glomerular Podocyte Injury via Regulating Histone
Tushuai Li1,2,3, Wenxue Sun4,5,6, Shenglong Zhu2,3
1School of Biology and Food Engineering, Changshu Institute of Technology, Suzhou, 215500, P.R. China.
Abstract:
T-2 toxin causes renal dysfunction with proteinuria and glomerular podocyte damage. This work explores the role of metabolic disorder/reprogramming-mediated epigenetic modification in the progression of T-2 toxin-stimulated podocyte injury. A metabolomics experiment is performed to assess metabolic responses to T-2 toxin infection in human podocytes. Roles of protein O-linked-N-acetylglucosaminylation (O-GlcNAcylation) in regulating T-2 toxin-stimulated podocyte injury in mouse and podocyte models are assessed. O-GlcNAc target proteins are recognized by mass spectrometry and co-immunoprecipitation experiments. Moreover, histone acetylation and autophagy levels are measured. T-2 toxin infection upregulates glucose transporter type 1 (GLUT1) expression and enhances hexosamine biosynthetic pathway in glomerular podocytes, resulting in a significant increase in β-arrestin-1 O-GlcNAcylation. Decreasing β-arrestin-1 or O-GlcNAc transferase (OGT) effectively prevents T-2 toxin-induced renal dysfunction and podocyte injury. Mechanistically, O-GlcNAcylation of β-arrestin-1 stabilizes β-arrestin-1 to activate the mammalian target of rapamycin (mTOR) pathway as well as to inhibit autophagy during podocyte injury by promoting H4K16 acetylation. To sum up, OGT-mediated β-arrestin-1 O-GlcNAcylation is a vital regulator in the development of T-2 toxin-stimulated podocyte injury via activating the mTOR pathway to suppress autophagy. Targeting β-arrestin-1 or OGT can be a potential therapy for T-2 toxin infection-associated glomerular injury, especially podocyte injury.
Insights
T-2 toxin causes kidney damage by affecting podocytes. This study reveals that O-linked N-acetylglucosaminylation (O-GlcNAcylation) of β-arrestin-1 is key, as inhibiting it protects against T-2 toxin-induced podocyte injury.
Area of Science:
- Nephrology
- Molecular Biology
- Epigenetics
Background:
- T-2 toxin induces renal dysfunction and podocyte damage.
- Metabolic reprogramming and epigenetic modifications are implicated in podocyte injury.
Purpose of the Study:
- To investigate the role of O-linked N-acetylglucosaminylation (O-GlcNAcylation) in T-2 toxin-induced podocyte injury.
- To elucidate the underlying molecular mechanisms involving metabolic and epigenetic changes.
Main Methods:
- Metabolomics analysis of human podocytes exposed to T-2 toxin.
- Assessing O-GlcNAcylation, β-arrestin-1, histone acetylation, and autophagy.
- Utilizing mass spectrometry and co-immunoprecipitation to identify O-GlcNAc targets.
- Employing mouse and podocyte models to evaluate therapeutic interventions.
Main Results:
- T-2 toxin upregulates glucose transporter type 1 (GLUT1) and enhances the hexosamine biosynthetic pathway.
- This leads to increased O-GlcNAcylation of β-arrestin-1, stabilizing it and activating the mTOR pathway.
- Inhibition of β-arrestin-1 or O-GlcNAc transferase (OGT) ameliorates T-2 toxin-induced renal and podocyte injury.
- O-GlcNAcylation of β-arrestin-1 suppresses autophagy by promoting H4K16 acetylation.
Conclusions:
- OGT-mediated β-arrestin-1 O-GlcNAcylation is a critical regulator of T-2 toxin-induced podocyte injury.
- This process involves mTOR pathway activation and autophagy inhibition.
- Targeting β-arrestin-1 or OGT presents a potential therapeutic strategy for T-2 toxin-associated glomerular and podocyte injury.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade

